Impact Factor
3.20
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.07
770 total citations
h5-index
30
h5 depth signal
Cited share
60.5%
233 of 385
Total citations
770
Citation footprint
Metric signal
2.06
External metric anchor
Self-citation
5.2%
40 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
1,707
China
218
United States
213
South Korea
53
Italy
41
Citing Fields of Research
Hematology
1,642
Lymphomas
664
Immunology
223
Oncology
107
Auto-Inflammatory Disorders
83
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,646
Articles tracked across the journal lifetime
Indexed publication set
385
233 cited publications
Last 12 months
214
17.8 publications/month
Open access share
29.4%
63 OA publications in the last year
Leading citing country
Japan
1,707 citing publications
Leading citing field
Hematology
1,642 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v54n1, 1991-
v54n1, 1991-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Lymphomas
Issuing & Sponsoring Bodies
Contributor
Nihon Ketsueki Gakkai
Broad Categories
Hematology
Lymphomas
MeSH Descriptors
Blood
Hematologic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s12185-026-04298-9
Open DOI
The prognostic impact of CDH1 and MEG3 methylation status in multiple myeloma
Epigenetic abnormalities, including DNA methylation, are thought to contribute to the pathobiology of multiple myeloma (MM). Recent studies have shown that the hypermethylation of tumor suppressor gene promoters is associated with MM pro...
02
DOI 10.1007/s12185-026-04295-y
Open DOI
Temporal trends in transfusion-transmitted cytomegalovirus infection among cytomegalovirus-seronegative HSCT recipients
Background: The incidence of transfusion-transmitted cytomegalovirus (TT-CMV) after hematopoietic stem cell transplantation (HSCT) in the era of universal leukoreduction remains unclear. This study evaluated temporal changes in TT-CMV an...
03
DOI 10.1007/s12185-026-04297-w
Open DOI
Clinical outcomes of upper-arm port implantation under restrictive platelet transfusion in hematological diseases
04
DOI 10.1007/s12185-026-04296-x
Open DOI
Cardiovascular events in aging Japanese people with hemophilia: a 3-year interim analysis of the ADVANCE Japan cohort
05
DOI 10.1007/s12185-026-04280-5
Open DOI
Clinical impact of infused CD3-positive cell dose in unrelated peripheral blood stem cell transplantation
06
DOI 10.1007/s12185-026-04294-z
Open DOI
Post-hoc analysis of induction failure in pediatric LCH: the JLSG-02 and LCH-12 clinical trials
Treatment options for refractory multisystem Langerhans cell histiocytosis (LCH) were not well established prior to the era of targeted therapy. We evaluated the efficacy and safety of cyclophosphamide, doxorubicin, vincristine, and pred...
07
08
DOI 10.1007/s12185-026-04288-x
Open DOI
Potential clinical benefits of early belumosudil treatment in chronic graft-versus-host disease
09
DOI 10.1007/s12185-026-04283-2
Open DOI
Current management of central nervous system involvement in chronic lymphocytic leukemia/small lymphocytic lymphoma
10
DOI 10.1007/s12185-026-04290-3
Open DOI
Dabrafenib plus trametinib in BRAF V600E-mutant Erdheim–Chester disease: a case series including CNS involvement
Background: Erdheim–Chester disease (ECD) is a rare clonal non-Langerhans cell histiocytosis characterized by the infiltration of foamy, CD68-positive/CD1a-negative histiocytes into multiple organ systems. Activating MAPK/ERK pathway mut...
Bibliographical & Catalog Notes
Place of publication varies.
Also issued online.
Journal of the Japanese Society of Hematology.
Vol. 54, no. 1 (FEB 1991)19910820 Notice published Printed on acid-free paper